News and media menu
Published date
- March 2023 (1)
- December 2022 (2)
- November 2022 (1)
- July 2022 (1)
- December 2021 (1)
- August 2021 (1)
- July 2021 (1)
- June 2021 (1)
- April 2021 (1)
- February 2021 (1)
- December 2020 (1)
- November 2020 (2)
- October 2020 (2)
- September 2020 (1)
- July 2020 (1)
- May 2020 (1)
- January 2020 (3)
- December 2019 (1)
- September 2019 (1)
- August 2019 (1)
- June 2019 (2)
- April 2019 (1)
- March 2019 (1)
- December 2018 (2)
- October 2018 (1)
- July 2018 (1)
- May 2018 (1)
- March 2018 (1)
- January 2018 (2)
- October 2017 (1)
- August 2017 (2)
- June 2017 (5)
- May 2017 (2)
- April 2017 (1)
- March 2017 (1)
- February 2017 (1)
- December 2016 (1)
- October 2016 (2)
- September 2016 (1)
- August 2016 (1)
- July 2016 (1)
Search
56 result(s) found, displaying 1 to 25
- Meeting statementsAACMC meeting 20, 9 December 2022The Australian Advisory Council on the Medicinal Use of Cannabis, Communiqué #20.
- NewsMedicinal Cannabis Program Regulatory Fees and Charges ReviewThis public consultation is open for comment until 10 February 2023.
- Meeting statementsAACMC meeting 19, 9 September 2022The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #19.
- NewsMedia release: Medicinal cannabis company Tikun Oceania fined $13,320 for alleged inadequate security and record-keepingThe Office of Drug Control within the Department of Health and Aged Care has issued Queensland-based Tikun Oceana Pty Ltd an infringement notice.
- Meeting statementsAACMC meeting 18, 11 March 2022The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #18.
- NewsODC Suspends Licences of Medicinal Cannabis Licence HolderOffice of Drug Control suspends cultivation and manufacture licences of Queensland Medicinal Cannabis Licence Holder.
- Meeting statementsAACMC meeting 17, 24 June 2021The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #17.
- NewsEnactment of the Narcotic Drugs Amendment (Medicinal Cannabis) Act 2021The Amendment Act provides for amendments to the Narcotic Drugs Act 1967 to support an innovative Australian medicinal cannabis industry for the benefit of Australian patients.
- Meeting statementsAACMC meeting 16, 9 April 2021The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #16.
- Meeting statementsAACMC meeting 15, 16 December 2020The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #15
- NewsIntroduction of the Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021Introduction of the Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021.
- NewsCommission on Narcotic Drugs votes on recommendations for cannabis and cannabis related substancesOn 2 December 2020, Australia voted at the Commission on Narcotic Drugs (CND) on six recommendations concerning the scheduling of cannabis and cannabis related substances, made by the World Health Organisation (WHO) in January 2019 to the CND.
- NewsMedicinal cannabis permit reform consultationThe ODC is seeking comments on a review of the structure, design and administrative processes relating to medicinal cannabis related permits.
- NewsCommencement of fees and charges for cannabis-related manufactureCost recovery arrangements for cannabis-related manufacture licences and permits commenced on 1 November 2020.
- Meeting statementsAACMC meeting 14, 23 September 2020The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #14.
- NewsIntroduction of fees and charges for cannabis-related manufactureFrom 1 November 2020, subject to formal approval from the Federal Executive Council, cost recovery arrangements will be extended to cannabis-related manufacture licences and permits under the Medicinal Cannabis Scheme.
- Meeting statementsAACMC meeting 13, 30 June 2020The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #13.
- NewsReforms to Medicinal Cannabis Scheme Fees and ChargesChanges to fees and charges related to the Medicinal Cannabis Scheme under the Narcotic Drugs Act 1967 commenced on 15 July 2020.
- Meeting statementsAACMC meeting 12, 21 April 2020The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #12.
- Meeting statementsAACMC meeting 11, 19 November 2019The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #11.
- Meeting statementsAACMC meeting 10, 12 June 2019The Australian Advisory Council on the Medicinal Use of Cannabis (AACMC), Communiqué #10.
- NewsSingle licence model consultation: Closing date for submissionsSubmissions in response to the Office of Drug Control's (ODCs) Consultation on Single Licence Model close COB Monday 3 February 2020.
- NewsImplementation of the Review of the Narcotic Drugs Act 1967 (Cth)The Office of Drug Control is implementing the 26 recommendations from the Report on the Review of the Narcotic Drugs Act 1967.
- NewsTabling of Report on the Review into the 2016 medicinal cannabis amendments to the Narcotic Drugs Act 1967Report on the Review into the 2016 medicinal cannabis amendments to the Narcotic Drugs Act 1967 was tabled in Parliament on Thursday 5 September 2019.
- NewsBoosting Australia's medicinal cannabis industryThe Australian Government will boost the nation's medicinal cannabis industry by prioritising projects that have been granted Major Project Status (MPS) and ultimately driving economic growth.
Pages
- Current page 1
- Page 2
- Page 3
- Next page Next ›
- Last page Last »